ClinicalTrials.gg
CompletedNCT03934853Updated May 2, 2019

Study to Confirm Accuracy and Safety of the Inliant Surgical Navigation System

An interventional study of Dynamic Dental Navigation in Partial Edentulism, sponsored by Navigate Surgical Technologies Inc.. Completed at 1 site in Canada. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2019-05-02.

Sponsored by Navigate Surgical Technologies Inc. · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled May 2018, registered Apr 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Not applicable
Ages
22 Years and older
Sex
All
01

Study summary

A confirmatory dual-clinic, non-randomized study of the Inliant device to aid in dental implant placement in humans. The hypothesis is that using the Inliant Surgical Navigation System ("Inliant") will provide a high degree of accuracy in multiple dimensions relative to the ideal implant position as determined in the planning stage, and will not result in any adverse outcomes related to use of the device. Five clinicians (Investigators) of various clinical backgrounds and experience will use the Inliant device, a licensed, medical device in Canada, to place a dental implant in a total of twenty (20) subjects.

Read the detailed description

The long term success of dental implant therapy is largely dependent on proper implant positioning in bone, and the facilitation of a well-functioning prosthesis. Surgical complications from implant placement in an incorrect location can include damage to adjacent teeth, sinus perforations, hemorrhage, buccal plate dehiscence, and nerve damage. In implant therapy, dynamic surgical guidance is a new technology used to facilitate accurate and efficient implant placement, and to aid in communication between the restorative dentist and surgeon.

The Inliant device is a dynamic surgical navigation system that is based on passive optical tracking technology. Passive optical tracking is accomplished by having the patient wear a reference body that is identified by an optical tracking system. This information allows the clinician to visualize the surgical drill projected onto a screen, showing its position in 3 dimensions on a CBCT scan of the patient. Dynamic surgical guidance has additional advantages over traditional methods in that it allows for intra-operative changes in implant planning, and allows the clinician to visualize the position of the surgical drill during the procedure.

The purpose of the present study is to analyze the accuracy of the Inliant device as a method of placing dental implants in an actual clinical setting and to confirm its safety.

02

Conditions studied

  • Partial Edentulism
03

In context

Lead sponsor

This is the only study on the registry with Navigate Surgical Technologies Inc. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Provide signed and dated informed consent form (ICF)
  • Willing to comply with all study procedures and be available for the study
  • Male or female, 22 years of age and older
  • In good general health as evidenced by medical history
  • To provide attachment of the stent for each implant, there must be at least two adjacent zero mobility teeth anywhere in the same arch on which the surgery is to be performed

Exclusion criteria

Exclusion Criteria:

  • A medical condition, psychological condition or dental condition that would exclude a patient from having dental implant surgery. Example: inability to tolerate local anesthesia or other dental disease conditions that would preclude dental implant surgery.
  • Use of disallowed concomitant medications (only if a contraindication to dental implant surgery. Examples include long term bisphosphonates, high dose blood thinners, etc.).
  • Pregnancy
  • Treatment with another investigational drug or other intervention
  • Inability to obtain a suitable pre-operative CBCT scan
  • In surgery, if there are clinical conditions that unexpectedly do not allow for the placement of an implant, e.g. lack of primary stability during immediate placement.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
53 participants (actual)

Study arms

  • Other
    No arm

    There is no arm for this study.

    Device: Dynamic Dental Navigation

Interventions

  • DeviceDynamic Dental Navigation

    Aid in dental implant placement in humans

06

What researchers measure

Primary outcomes

  1. Accuracy of implant placement

    Uses passive optical tracking technology pre-operatively to plan dental implant placement. Uses the same technology post-operatively for placement comparison assessment.

    Time frame: +/- 7 days of implant procedure

Secondary outcomes

  1. Safety assessment through collection of adverse event data

    Assessment of safety in a clinical environment as determined by review of adverse events related to the use of the device

    Time frame: +/- 7 days of implant procedure

07

Study locations

1 site
  • McGill University Health Center
    Montreal, Quebec, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03934853
Lead sponsor
Navigate Surgical Technologies Inc.
Responsible party
Sponsor
First posted
May 2, 2019
Start date
May 29, 2018
Primary completion
Jan 14, 2019
Completion
Mar 12, 2019
Last update
May 2, 2019

Study contacts

Nicholas M Makhoul
principal investigator · McGill University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion